Addiction Treatment Medication Psychotherapy Decisions
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Addiction Treatment Medication Psychotherapy Decisions
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
This episode is a deep dive from The Carlat Addiction Treatment Report. It examines various evidence-based strategies for managing substance use disorders, specifically comparing pharmacological and psychotherapeutic interventions. It features an in-depth look at motivational interviewing, highlighting how collaborative dialogue and the resolution of ambivalence can drive a patient's commitment to recovery. Another focal point is 12-step facilitation, a clinical framework designed to bridge the gap between professional therapy and community-based support groups. The sources also introduce Brixadi, a flexible, long-acting injectable buprenorphine, as a modern tool for treating opioid use disorder in both outpatient and acute care settings. Ultimately, the material serves as a clinical guide to tailoring addiction treatment based on the specific substance involved and the unique needs of the individual.